Coronavírus — Por que nem todos que vão ao hospital com os sintomas do Covid-19 fazem o teste?
In the realm of allergic and immune-mediated diseases, the topic Covid-19 It occupies a prominent position due to the frequency with which it impacts the daily well-being of children, adults, and the elderly. This publication was prepared with the purpose of fully elucidating the issue. "Coronavírus — Por que nem todos que vão ao hospital com os sintomas do Covid-19 fazem o teste?", offering a structured overview from pathophysiology to diagnostic investigation and the safe prevention of new crises.
✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project
Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.
Desafios na testagem para COVID-19 e a importância do diagnóstico
Uma das grandes dúvidas que surgiram durante o período mais crítico da pandemia de COVID-19 diz respeito à disponibilidade e à realização de exames diagnósticos para todas as pessoas que procuravam atendimento médico com sintomas respiratórios compatíveis com a doença. A questão logística e estratégica envolvendo a distribuição e a aplicação em massa de testes sempre representou um enorme desafio para os sistemas de saúde públicos e privados.
Do ponto de vista da prática médica e da saúde pública, o ideal é que a testagem em massa seja amplamente realizada. Identificar rapidamente os casos positivos auxilia diretamente na redução da morbimortalidade associada ao vírus, pois permite que o paciente adote medidas preventivas de isolamento domiciliar, proteja seus familiares e receba o acompanhamento adequado. No entanto, questões operacionais e administrativas de cada gestão municipal, estadual ou federal influenciam diretamente a dinâmica de disponibilização desses exames à população.
Diante de sintomas compatíveis com a infecção pelo coronavírus, a recomendação clínica geral envolve a investigação diagnóstica por meio de métodos específicos, que devem ser interpretados com o devido rigor técnico:
- Teste RT-PCR (Swab): Considerado o método padrão para a detecção do material genético do vírus na fase aguda da infecção. Vale destacar que, em alguns casos, pode ocorrer um resultado Falso-Negativo inicial. Por isso, diante de forte suspeita clínica e persistência dos sintomas, o médico pode avaliar a necessidade de repetir o exame para maior segurança diagnóstica.
- Testes sorológicos (Pesquisa de anticorpos): Indicados geralmente após o período de 14 a 21 dias do início dos sintomas. Servem para identificar a presença de anticorpos como IgM e IgG, demonstrando a resposta do sistema imunológico ao vírus.
Além da resposta humoral clássica com a produção de anticorpos, a comunidade científica também passou a estudar o papel fundamental da imunidade inata — aquela com a qual o indivíduo já nasce — na defesa inicial do organismo contra o coronavírus, demonstrando que a complexidade da resposta imunológica vai muito além da simples mensuração de anticorpos circulantes.
This content is strictly educational and informative in nature and should in no way replace consultation, diagnosis, and individualized evaluation with a specialist physician.
Developments in Evidence-Based Medicine: Vaccine Immunology and Allergen-Specific Immunotherapy
In Evidence-Based Medicine (WHO, EAACI and ASBAI), two complementary strategies for modulating the immune system are distinguished: (1) the preventive anti-infectious immunizing vaccines, which stimulate humoral (neutralizing IgG/IgA antibodies) and cellular (memory T lymphocytes) adaptive immunity against viral and bacterial pathogens; and (2) a Allergen-specific immunotherapy (allergy vaccines), the only treatment that modifies the natural history of IgE-mediated allergic diseases. The controlled and progressive administration of standardized allergenic extracts promotes an immunological shift from the Th2 to the Th1 profile, inducing the expansion of regulatory T lymphocytes (CD4)+CD25+FOXP3+) producers of IL-10 and TGF-β and stimulates the synthesis of IgG4 subclass blocking antibodies, thus sustainably reducing clinical hyper-reactivity and the need for symptomatic drugs.
💎 Diamond Plan — Safe immunization, even for those with a history of allergies. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Safe Immunization, Immune Response, and Protection of the Allergic Patient
Vaccine Mechanisms, Excipients, and Assessment of Immune Competence
In assessing the competence of the immune system—whether in recurrent infections, laboratory alterations in immunoglobulins (IgG, IgA, IgM, IgE), or in people living with HIV under monitoring of CD4 T lymphocyte counts—a careful distinction is made between the use of inactivated/subunit vaccines (widely safe even in immunocompromised individuals) and live attenuated vaccines, whose indication depends on the degree of preservation of cellular immunity. Furthermore, patients undergoing allergy immunotherapy can maintain their vaccination schedule, respecting only small operational intervals as directed by the medical team.
Integration between Vaccination Schedule, Allergy Tests and Baseline Monitoring
Individualized assessment by an allergist and immunologist correlates laboratory tests of cellular and humoral immunity with the patient's actual clinical history. Combining the allergy test well indicated for preventive monitoring — including allergy vaccine In cases of atopic dermatitis, and with immunostimulant vaccines when applicable, broad, safe protection based on scientific evidence is guaranteed.
Epithelial Dysfunction, Skin Microbiome, and Delayed Sensitization
The skin acts as the first organ of immune defense in the human body. In atopic dermatitis, genetic alterations in structural proteins of the stratum corneum (such as filaggrin) and in the composition of ceramides cause transepidermal water loss, pronounced dryness, and facilitated entry of mites and aeroallergens. This microenvironment activates Th2 cytokines (especially IL-4, IL-13, and IL-31, directly linked to intense itching) and favors colonization by Staphylococcus aureus, whose superantigens perpetuate eczematous flare-ups.
Impact on Quality of Life, Sleep, and Systemic Well-being
Além das manifestações físicas diretas, quadros não controlados ligados a Covid-19 interferem profundamente na arquitetura do sono reparador, na capacidade de concentração escolar e profissional e no equilíbrio emocional. O estresse crônico, por meio de mediadores neuroendócrinos e alarminas epiteliais, retroalimenta a resposta inflamatória imunitária. Dessa forma, instituir uma abordagem integral de reabilitação clínica e ambiental restaura a autonomia diária e o bem-estar global do indivíduo.
Importance of Differential Diagnosis and Detailed Medical History
Na especialidade de Alergia e Imunologia, dois pacientes com sintomas aparentemente semelhantes envolvendo Covid-19 podem apresentar mecanismos fisiopatológicos completamente distintos. Por essa razão, a história clínica minuciosa — investigando cronologia das crises, ambiente domiciliar e profissional, histórico familiar de atopia, uso de fármacos concomitantes e hábitos alimentares — funciona como bússola indispensável para interpretar corretamente exames laboratoriais (como dosagem de IgE total e específica) e provas funcionais. Um resultado laboratorial isolado jamais substitui o julgamento clínico presencial ou por telemedicina especializada, prevenindo diagnósticos equivocados e tratamentos desnecessários.
Diamond Plan: Specialized Allergy Treatment Wherever You Are
We know that, for many families, allergy treatment faces two concrete obstacles: high cost of allergy vaccines and the distance to a specialized centerThe Diamond Plan It was created precisely to remove these barriers, combining teleconsultation with specialists and easy access to immunotherapy throughout the country. Safe immunization, even for those with a history of allergies.
Why do patients across Brazil choose the Diamond Plan?
- Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
- easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
- A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
- Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
- National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.
More than 30 years caring for people with allergies.
Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.
START TODAY
Your expert consultation is just a click away.
I want to join the Diamond Plan.Schedule a teleconsultation
Official telemedicine environment: brasilsemalergia.online
Do you prefer to be served in person?
Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:
- Rio de Janeiro: Realengo (West Zone), North Zone, Duke of Caxias, Xerém, New Iguaçu, Itaguaí, Niterói, Iguaba Grande and Saint Peter of the Village (Lakes Region).
- São Paulo: Campo Limpo (South Zone).
- Paraná: Curitiba.
Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.
The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.
Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.
Conclusion and Summary of Guidelines
It is concluded that the efficient management of issues related to Covid-19 It relies on the combination of high-quality scientific information, environmental prevention, and therapy tailored to each patient's profile. In the face of persistent or recurring symptoms, seek evaluation with an allergist and immunologist—integrating thorough diagnostic investigation and established treatment options. rhinitis treatment Whenever indicated — ensures clinical safety and long-lasting health protection.
Scientific references and authoritative sources
The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information:




